On August 29, 2018 Can-Fite BioPharma (CANF), reported it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City (Press release, Can-Fite BioPharma, AUG 29, 2018, View Source [SID1234529125]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Motti Farbstein, CFO of Can-Fite, will provide an overview of the Company’s business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.rodmanevents.com ) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.

Event: 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC

Date: Wednesday, September 5, 2018

Time: 3:00-3:25 PM (Eastern Time)

Location: Louis XVI A (2nd floor); St. Regis New York Hotel in New York City

The presentation will be webcast live. To access the webcast, please visit www.rodmanevents.com. The webcast replay will remain available for 90 days following the live presentation.

On August 29, 2018 Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, reported that company management will participate in fireside chats at the following upcoming investor conferences (Press release, Loxo Oncology, AUG 29, 2018, View Source [SID1234529124]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi Annual Biotech Conference in Boston on September 5, 2018 at 8:45 a.m. ET

Morgan Stanley Global Healthcare Conference in New York City on September 13, 2018 at 9:10 a.m. ET

Live webcasts of the fireside chats will be available at View Source

On August 29, 2018 Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, reported that Dr. Bassam Damaj, President & Chief Executive Officer, and Ryan Selhorn, Vice President, Chief Financial Officer, will present at the 2018 H.C. Wainwright 20th Annual Global Investment Conference, on Thursday, September 6, 2018 (Press release, Innovus Pharmaceuticals, AUG 29, 2018, View Source [SID1234529122]). They will present an update on the Company’s growing revenues, the launch of new products, its path to profitability and its other business plans.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Damaj and Mr. Selhorn will be meeting with members of the investment community during one-on-one meetings at the conference as well. The corporate presentation will be available for download on the Innovus Pharma web site (www.innovuspharma.com).

About Conference Presentation Time

Event: H.C. Wainwright 20th Annual Global Investment Conference

Date: Thursday, September 6, 2018

Time: 10:25 AM-10:50 AM EDT

Location: St. Regis New York at 2 E 55th St., New York, NY 10022

On August 29, 2018 Zymeworks Inc. (NYSE/TSX: ZYME), a clinical‑stage biopharmaceutical company developing multifunctional biotherapeutics, reported that management will present at the upcoming 13th Annual Wells Fargo Securities Healthcare Conference taking place September 5-6, 2018 in Boston, MA (Press release, Zymeworks, AUG 29, 2018, View Source [SID1234529121]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will provide a corporate update and present upcoming catalysts on Wednesday, September 5, 2018 at 3:35 p.m. ET. Interested parties can access a live webcast of the presentation via a link from Zymeworks’ website at View Source, which will also host a recorded replay available afterwards

On August 29, 2018 Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient’s immune system against cancer, reported it will present at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC (Press release, Heat Biologics, AUG 29, 2018, https://ir.heatbio.com/news/detail/607/heat-biologics-to-present-at-the-20th-annual-rodman-renshaw-global-investment-conference-in-new-york-city [SID1234529118]). The conference is being held on September 4-6, 2018 at The St. Regis New York in New York City.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jeff Wolf, Founder and Chief Executive Officer of Heat Biologics, will provide an overview of the Company’s business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

Event: 20th Annual Rodman & Renshaw Global Investment Conference

Date: Wednesday, September 5, 2018

Time: 4:40-5:05 PM (Eastern Time)

Location: Louis XVI B; The St. Regis New York

If you are unable to attend and would like to view the Company’s live webcast, please click on the following link (View Source).